The prognostic role of hemoglobin levels in patients undergoing concurrent chemo-radiation for anal cancer.

about

The prognostic role of hemoglobin levels in patients undergoing concurrent chemo-radiation for anal cancer.

Item

http://www.wikidata.org/entity/Q55250545

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

The prognostic role of hemoglo ...... emo-radiation for anal cancer.

@en

The prognostic role of hemoglo ...... emo-radiation for anal cancer.

@nl

type

Item

label

The prognostic role of hemoglo ...... emo-radiation for anal cancer.

@en

The prognostic role of hemoglo ...... emo-radiation for anal cancer.

@nl

prefLabel

The prognostic role of hemoglo ...... emo-radiation for anal cancer.

@en

The prognostic role of hemoglo ...... emo-radiation for anal cancer.

@nl

P1476

The prognostic role of hemoglo ...... hemo-radiation for anal cancer

@en

P2093

Chiara Casadei

http://www.w3.org/2001/XMLSchema#string

Francesca Arcadipane

http://www.w3.org/2001/XMLSchema#string

Francesco Montagnani

http://www.w3.org/2001/XMLSchema#string

Giuseppe Carlo Iorio

http://www.w3.org/2001/XMLSchema#string

Kalliopi Andrikou

http://www.w3.org/2001/XMLSchema#string

Lorenzo Fornaro

http://www.w3.org/2001/XMLSchema#string

Mario Scartozzi

http://www.w3.org/2001/XMLSchema#string

Massimiliano Mistrangelo

http://www.w3.org/2001/XMLSchema#string

Paola Cassoni

http://www.w3.org/2001/XMLSchema#string

Stefania Martini

http://www.w3.org/2001/XMLSchema#string

P2860

Cancer statistics, 2008

Hematologic toxicity in anal cancer patients during combined chemo-radiation: a radiation oncologist perspective.

Prognostic factors derived from a prospective database dictate clinical biology of anal cancer: the intergroup trial (RTOG 98-11)

Intensity-modulated radiation therapy with simultaneous integrated boost combined with concurrent chemotherapy for the treatment of anal cancer patients: 4-year results of a consecutive case series.

Volumetric modulated arc therapy (VMAT) in the combined modality treatment of anal cancer patients

Dosimetric predictors of acute hematologic toxicity during concurrent intensity-modulated radiotherapy and chemotherapy for anal cancer.

Early-stage Node-negative (T1-T2N0) Anal Cancer Treated with Simultaneous Integrated Boost Radiotherapy and Concurrent Chemotherapy.

Locally Advanced (T3-T4 or N+) Anal Cancer Treated with Simultaneous Integrated Boost Radiotherapy and Concurrent Chemotherapy.

Outcomes and prognostic factors for squamous-cell carcinoma of the anal canal: analysis of patients from the National Cancer Data Base.

RTOG 0529: a phase 2 evaluation of dose-painted intensity modulated radiation therapy in combination with 5-fluorouracil and mitomycin-C for the reduction of acute morbidity in carcinoma of the anal canal

P2888

s13014-018-1035-9

P304

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S13014-018-1035-9

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Pierfrancesco Franco

Stefano Cascinu

Andrea Casadei Gardini

P577

2018-05-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1103737361

http://www.w3.org/2001/XMLSchema#string

P698

29720197

http://www.w3.org/2001/XMLSchema#string

P932

5930791

http://www.w3.org/2001/XMLSchema#string